Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples